This inventor holds 4 USPTO granted patents and 10 published patent applications. Top assignees: Konkuk University Glocal Industry-Academic Collaboration Foundation, Sungkyunkwan University, Yonsei University. Active years: 1980-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8 
1 out of 1,364 
1 out of 1,492 
Years Active: 1980-2023
Title: Innovations of Sung Jae Shin: A Pioneer in Myeloid-Derived Suppressor Cells
Introduction: Sung Jae Shin, a prominent inventor based in Seoul, South Korea, has made significant contributions to the field of medical research through his innovative work. With a total of four patents under his name, he focuses on advancing the understanding and treatment of sepsis and related conditions.
Latest Patents: Among his latest inventions is a method for producing myeloid-derived suppressor cells (MDSCs). This method involves inducing the differentiation of bone marrow cells into MDSCs through treatment with a toll-like receptor agonist or type I interferon. Additionally, he has developed compositions aimed at preventing or treating sepsis or septic shock, which actively utilize adenosine kinase (ADK) protein as an ingredient. These compositions demonstrate the potential to inhibit the binding of lipopolysaccharides (LPS) and enhance therapeutic effects against sepsis by improving animal model viability and reducing inflammatory responses.
Career Highlights: Sung Jae Shin has a distinguished career marked by his dedication to research and innovation. His expertise is reflected in his patents and the advancements they forge in medical technology. His work not only addresses critical challenges in healthcare but also sets the stage for future developments in the treatment of severe infections.
Collaborations: Throughout his career, Shin has collaborated with esteemed institutions, including the Konkuk University Glocal Industry-Academic Collaboration Foundation and Yonsei University. He has also worked alongside notable colleagues such as Yeong Min Park and In Duk Jung, contributing to a dynamic and innovative research environment.
Conclusion: Sung Jae Shin stands as a notable innovator whose patents and research endeavors focus on complex medical issues. His contributions, particularly in the production and application of myeloid-derived suppressor cells, are vital in the ongoing fight against sepsis and highlight the importance of collaboration in advancing scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile